We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Tolerability and Safety of Large-Volume Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administered with or without Dose Ramp-Up: A Phase 1 Study in Healthy Participants

    Purpose

    Facilitated subcutaneous immunoglobulin (fSCIG; immune globulin infusion 10% [human] with recombinant human hyaluronidase [rHuPH20]) permits...

    Zhaoyang Li, Andras Nagy, ... Leman Yel in Journal of Clinical Immunology
    Article Open access 19 June 2024
  2. Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects

    Introduction

    To assess the safety, tolerability and pharmacokinetics of a single dose of SYHA1402 in healthy Chinese subjects.

    Methods ...
    Beibei Liang, ** Wang, ... Yun Cai in Neurology and Therapy
    Article Open access 24 April 2023
  3. Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

    Objectives

    To update and assess the efficacy and tolerability of once weekly subcutaneous semaglutide in patients with type 2 diabetes (T2D).

    ...
    Shanshan Hu, **aorong Su, Guorong Fan in Diabetology & Metabolic Syndrome
    Article Open access 28 October 2023
  4. How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?

    Background

    There is increasing interest in patient-reported measures of cancer treatment tolerability. A global measure of bother, the FACT GP5 item...

    John Devin Peipert, Sara Shaunfield, ... David Cella in Supportive Care in Cancer
    Article Open access 16 December 2022
  5. Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer

    Background

    In patients with metastatic castration-resistant prostate cancer, darolutamide was well tolerated for 25 months, but minimal long-term...

    Robert Hugh Jones, Karim Fizazi, ... Egils Vjaters in Prostate Cancer and Prostatic Diseases
    Article Open access 26 October 2023
  6. Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant Recipients

    Introduction

    Acquired amyloid neuropathy is an iatrogenic disease that appears years after a domino liver transplant. The objectives of our study are...

    Velina Nedkova-Hristova, Laura Donadeu, ... Carlos Casasnovas in Neurology and Therapy
    Article Open access 10 May 2024
  7. A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults

    Purpose

    Hyaluronidase-facilitated subcutaneous immunoglobulin (fSCIG) 20% will allow reduced infusion volumes and frequency versus existing...

    Andras Nagy, Kimberly Duff, ... Zhaoyang Li in Journal of Clinical Immunology
    Article Open access 22 December 2023
  8. SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants

    Background

    The intravenous (IV) formulation of Rho-kinase (ROCK) inhibitor fasudil has been approved for the treatment of subarachnoid haemorrhage...

    Andreas W. Wolff, Jörg Peine, ... Paul Lingor in CNS Drugs
    Article Open access 28 February 2024
  9. Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study

    Introduction

    Long-term (1-year) fremanezumab treatment proved to be effective, safe, and well tolerated in individuals with migraine and < 2...

    Piero Barbanti, Gabriella Egeo, ... Paola Torelli in Neurology and Therapy
    Article Open access 07 March 2024
  10. Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

    This open-label, extension study assessed long-term safety, tolerability, and efficacy of ambrisentan in a pediatric population (age 8– < 18 years)...

    Dunbar Ivy, Maurice Beghetti, ... Rolf M. F. Berger in European Journal of Pediatrics
    Article Open access 16 February 2024
  11. Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis

    Background

    Which antimicrobial agents provide the optimal efficacy, safety, and tolerability for the empirical treatment of complicated...

    Wenqiang Kong, Ting Deng, ... Yanyan Wu in BMC Infectious Diseases
    Article Open access 21 April 2023
  12. Efficacy, feasibility and tolerability of ketogenic diet for the treatment of poor response to bariatric surgery

    Purpose

    Poor response to bariatric surgery, namely insufficient weight loss (IWL) or weight regain (WR), is a critical issue in the treatment of...

    F. Vinciguerra, S. Longhitano, ... L. Frittitta in Journal of Endocrinological Investigation
    Article Open access 21 February 2023
  13. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers

    Background and Objective

    QX006N is a novel, humanized, IgG4κ monoclonal antibody targeting IFNAR1, developed for the treatment of systemic lupus...

    **aojiao Li, Bing Li, ... Yanhua Ding in BioDrugs
    Article 27 December 2023
  14. Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC

    There is a lack of effective programmed cell death protein 1 (PD-1)‐targeted immunotherapy with good tolerability in patients with advanced...

    Ting Li, Jiang Guo, ... Fanpu Ji in Cancer Immunology, Immunotherapy
    Article Open access 25 February 2023
  15. Tolerability of N-chlorotaurine in comparison with routinely used antiseptics: an in vitro study on chondrocytes

    Background

    Currently, povidone-iodine (PVP-I) and hydrogen peroxide (H 2 O 2 ) are frequently used antiseptics in joint infections, but the cytotoxic...

    Magdalena Pilz, Kevin Staats, ... Johannes Holinka in Pharmacological Reports
    Article Open access 17 May 2024
  16. Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

    Background and Objectives

    BI 1358894, a novel small-molecule inhibitor of transient receptor potential canonical ion channels, is under development...

    Jangsoo Yoon, Vikas Sharma, Akiko Harada in Clinical Drug Investigation
    Article Open access 24 April 2024
  17. Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials

    Background

    Conventional, non-specific preventive migraine treatments often demonstrate low rates of treatment persistence due to poor efficacy or...

    Paul Rizzoli, Michael J. Marmura, ... Messoud Ashina in The Journal of Headache and Pain
    Article Open access 11 March 2024
  18. Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience

    Advanced Parkinson’s Disease (APD) is complicated by the emergence of motor and non-motor fluctuations, which are initially predictable and...

    Vinod Metta, Ra**der K. Dhamija, ... Rupam Borgohain in Scientific Reports
    Article Open access 31 October 2023
  19. Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN2COVID Phase I Randomized Trial

    Background and Objectives

    Interferons have been identified as a potential treatment alternative for coronavirus disease 2019. This study assessed the...

    Diego Garcia-Huidobro, Carolina Iturriaga, ... Lidia Pontanilla in Clinical Drug Investigation
    Article 22 June 2023
  20. Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson’s: a study protocol

    Background

    Parkinson’s disease (PD) is the fastest growing neurological condition worldwide. Recent theories suggest that symptoms of PD may arise due...

    Hilmar P. Sigurdsson, Heather Hunter, ... Alison J. Yarnall in BMC Neurology
    Article Open access 03 February 2023
Did you find what you were looking for? Share feedback.